|
|
|
Insider
Information: |
Hassan Fred |
Relationship: |
Director |
City: |
Kenilworth |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
2,176,602 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$8,180,500 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
2,176,602 |
|
|
Total
Value |
$8,180,500 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
Percentage
Gain/Loss : |
-18.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Merck & Co Inc |
MRK |
Chairman and CEO, Dire... |
2009-11-03 |
0 |
2003-11-26 |
0 |
Premium* |
|
Avon Products Inc |
AVP |
Director |
2011-02-25 |
49,079 |
2004-05-06 |
0 |
Premium* |
|
Time Warner Inc |
TWX |
|
2018-06-14 |
0 |
2010-03-03 |
0 |
Premium* |
|
Bausch Health Companies Inc |
BHC |
Director |
2013-08-29 |
53,969 |
2013-08-22 |
0 |
Premium* |
|
Amgen Inc |
AMGN |
Director |
2020-05-05 |
9,191 |
2015-08-04 |
0 |
Premium* |
|
Precigen Inc |
PGEN |
Director |
2024-03-14 |
1,029,834 |
2016-12-01 |
0 |
Premium* |
|
Bridgebio Pharma, Inc. |
BBIO |
Director |
2021-12-29 |
19,300 |
2021-12-29 |
0 |
Premium* |
|
Cocrystal Pharma |
COCP |
Director |
2023-04-20 |
1,015,229 |
|
0 |
Premium* |
|
Prometheus Biosciences, Inc. |
RXDX |
Director |
2023-06-16 |
0 |
2023-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RXDX |
Prometheus Biosciences, I... |
Director |
|
2023-06-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,123) |
0 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2023-08-14 |
4 |
B |
$1.75 |
$998,104 |
D/D |
570,345 |
878,942 |
2.39 |
% |
|
PGEN |
Precigen Inc |
Director |
|
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
106,837 |
985,779 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2024-03-14 |
4 |
A |
$1.43 |
$62,999 |
D/D |
44,055 |
1,029,834 |
0 |
- |
|
COCP |
Cocrystal Pharma |
Director |
|
2023-04-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,015,229 |
|
% |
|
55 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|